The trajectory of growth in the Schnitzler Syndrome Disease Treatment Market is fundamentally driven by a confluence of scientific discovery, improved diagnostic capabilities, and supportive regulatory frameworks worldwide. This growth is not solely reflected in the volume of prescriptions, which remains low due to the disease's rarity, but rather in the significant increase in market...